Knowledge and practice of community pharmacists towards SGLT2 inhibitors [version 2; peer review: 3 approved]

Knowledge and practice of community pharmacists towards SGLT2 inhibitors [version 2; peer review: 3 approved]

Background: Sodium/glucose cotransporter 2 (SGLT2) inhibitors are a new class of oral anti-diabetic drugs which improve glycaemic control in type 2 diabetes mellitus (T2DM) by preventing the kidney from reabsorbing glucose back to blood. Community pharmacists have long-term relationships with most o...

Full description

Bibliographic Details
Main Authors: Omar Gammoh, Manar Alajarmeh, Elaf Yousef, Majd Abu Gneam, Roaa Alnajjar, Esam Qnais, Mohammed Wedyan, Muna Oqal, Ahmad Al-Samdi, Abdelrahim Alqudah
Format: Article
Language:English
Published: F1000 Research Ltd 2022-06-01
Series:F1000Research
Subjects:
Diabetes
SGLT2 inhibitors
Pharmacists
Jordan
eng
Online Access:https://f1000research.com/articles/11-659/v2

Internet

https://f1000research.com/articles/11-659/v2

Similar Items